Publication

A Cross Talk between Neuronal Urokinase-type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain

Downloadable Content

Persistent URL
Last modified
  • 05/15/2025
Type of Material
Authors
    Ariel Diaz, Emory UniversityPaola Merino, Emory UniversityLuis Guillermo Manrique, Emory UniversityJuan Pablo Ospina, Emory UniversityLihong Cheng, Emory UniversityFang Wu, Emory UniversityValerie Jeanneret, Emory UniversityManuel Yepes, Emory University
Language
  • English
Date
  • 2017-10-25
Publisher
  • Society for Neuroscience
Publication Version
Copyright Statement
  • © 2017 the authors
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0270-6474
Volume
  • 37
Issue
  • 43
Start Page
  • 10310
End Page
  • 10322
Grant/Funding Information
  • This work was supported in part by the National Institutes of Health (Grant NS-091201 to M.Y. and Grant NS-079331 to M.Y.) and the Veterans Administration (MERIT Award IO1BX003441 to M.Y.).
Abstract
  • Urokinase-type plasminogen activator (uPA) is a serine proteinase that, upon binding to its receptor (uPAR), catalyzes the conversion of plasminogen into plasmin on the cell surface. Our previous studies indicate that uPA and uPAR expression increase in the ischemic brain during the recovery phase from an acute ischemic injury and that uPA binding to uPAR promotes neurological recovery after an acute ischemic stroke. Here, we used male mice genetically deficient on either uPA (uPA−/−) or uPAR (uPAR−/−) or with a four-amino acid substitution into the growth factor domain of uPA that abrogates its binding to uPAR (PlatGFDhu/GFDhu) to investigate the mechanism whereby uPA promotes neurorepair in the ischemic brain. We found that neurons release uPA and astrocytes recruit uPAR to their plasma membrane during the recovery phase from a hypoxic injury and that binding of neuronal uPA to astrocytic uPAR induces astrocytic activation by a mechanism that does not require plasmin generation, but instead is mediated by extracellular signal-regulated kinase 1/2 (ERK1/2)-regulated phosphorylation of the signal transducer and activator of transcription 3 (STAT3). We report that uPA/uPAR binding is necessary and sufficient to induce astrocytic activation in the ischemic brain and that astrocytes activated by neuronal uPA promote synaptic recovery in neurons that have suffered an acute hypoxic injury via a mechanism mediated by astrocytic thrombospondin-1 (TSP1) and synaptic low-density lipoprotein receptor-related protein-1 (LRP1). In summary, we show that uPA/uPAR-induced astrocytic activation mediates a cross talk between astrocytes and injured neurons that promotes synaptic recovery in the ischemic brain.
Author Notes
  • Correspondence should be addressed to Manuel Yepes, Department of Neurology and Center for Neurodegenerative Disease, Emory University, Whitehead Biomedical Research Building, 615 Michael Street, Suite 505J, Atlanta, GA 30322., myepes@emory.edu
Keywords
Research Categories
  • Health Sciences, Pharmacology
  • Biology, Neuroscience

Tools

Relations

In Collection:

Items